|
This publication is made possible by an educational grant from Amgen
|
Volume 51, Number 2
Rheumatic Manifestations of Gastrointestinal Diseases
Ibrahim S. Alghafeer, MD
Fellow, Division of Rheumatology
University of Medicine and Dentistry of New Jersey
New Brunswick, NJ
Leonard H. Sigal, MD
Professor and Chief, Division of Rheumatology
University of Medicine and Dentistry of New Jersey
New Brunswick, NJ
Gastrointestinal Pathophysiology
The gut has multiple mechanisms to regulate the
efficient absorption of nutrients while excluding bacterial and dietary
antigens. Impairment of the gastrointestinal barrier function can be observed in
several diseases including inflammatory bowel disease (IBD) and other
spondyloarthropathies, and this defect may play a role in the pathogenesis of
arthropathies.
Illeocolonoscopy and multiple biopsies were
carried out in 96 patients with seronegative spondyloarthropathy, 17 patients
with osteoarthritis taking nonsteroidal anti-inflammatory drugs (NSAIDs), and 19
patients with chronic abdominal discomfort. Inflammatory gut lesions were
detected in two thirds of the patients with spondyloarthropathy, 12.5% of
patients with osteoarthritis, and 16% of patients with abdominal discomfort.
More recently, an Italian study confirmed microscopical mucosal inflammation on
biopsy in 15 people with psoriatic arthritis but without bowel symptoms, 6 of
whom had normal appearing mucosa by colonoscopy (2).
Altered gut permeability may also play a role in
the pathogenesis of arthropathies. Permeability may be measured by oral feeding
of different tracers (eg, 51Cr-labeled EDTA, lactoglobulin, lactalbumin,
polyethylene glycol particles, lactulose, or mannitol) followed by urine
analysis of excretion. Increased intestinal permeability was found in all
subtypes of juvenile chronic arthritis with correlation between abnormalities in
lactulose/mannitol test and the histopathological features of the gut mucosa
(3). Another study showed an increase in the 24-hour urine excretion of
51Cr-EDTA in 34 patients with Behcet’s syndrome and 10 patients with
ankylosing spondylitis (AS), when compared with 15 healthy controls (4).
Because the results obtained from such studies
are entirely dependent on normal gastric emptying, normal renal function, and an
accurate urine collection, they should be interpreted carefully. Also, the
results may be altered by possible effect of the NSAIDs on prostaglandin
synthesis and gut permeability.
Most recently, Salmi et al concluded that
different leukocyte populations derived from inflamed gut of patients with IBD
bind avidly to synovial vessels using a distinct repertoire of adhesion
molecules, suggesting that their recirculation may contribute to the development
of reactive arthritis in inflammatory bowel diseases (5). This study is the
first experimental support of the homing of lymphocytes from the gut mucosa to
joint tissue in enteropathic arthritis.

|